The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications.
Seyed Hossein ShahcheraghiFateme SalemiWaqas AlamHenry AshworthLuciano SasoHaroon KhanMarzieh LotfiPublished in: Medical oncology (Northwood, London, England) (2022)
Glioblastoma multiforme (GBM) grade IV glioma is the most frequent and deadly intracranial cancer. This tumor is determined by unrestrained progression, uncontroled angiogenesis, high infiltration and weak response to treatment, which is chiefly because of abnormal signaling pathways in the tumor. A member related to the Cap 'n' collar family of keypart-leucine zipper transcription agents-the transcription factor NF-E2-related factor 2 (Nrf2)-regulates adaptive protection answers by organized upregulation of many genes that produce the cytoprotective factors. In reply to cellular pressures types such as stresses, Nrf2 escapes Kelch-like ECH-related protein 1 (Keap1)-facilitated suppression, moves from the cytoplasm towards the nucleus and performs upregulation of gene expression of antioxidant responsive element (ARE). Nrf2 function is related tocontrolling many types of diseases in the human specially GBM tumor.Thus, we will review the epigeneticalregulatory actions on the Nrf2/Keap1 signaling pathway and potential therapeutic options in GBM by aiming the stimulation of Nrf2.
Keyphrases
- oxidative stress
- signaling pathway
- transcription factor
- gene expression
- pi k akt
- endothelial cells
- induced apoptosis
- epithelial mesenchymal transition
- cell proliferation
- dna methylation
- poor prognosis
- genome wide
- vascular endothelial growth factor
- immune response
- dna binding
- anti inflammatory
- drug induced
- combination therapy
- induced pluripotent stem cells
- wound healing